retatrutide with mots c MOTS-C Stacked - My Initial Impressions Retatrutide Melanotan 2 Bundle |

A paper published October 2025 assessed whether non-diabetic overweight or obese patients who took GLP-1 agonists were more likely to develop AMD from no disease at baseline, compared to patients who took other weight loss drugs

The clinician applies established medical guidelines to determine whether a GLP-1 medication is appropriate for your individual situation

GLP-1s vs surgery is a useful clinical comparison, but both focus on treating individuals

The dominant mechanism identified across the medical literature is telogen effluvium , a diffuse, non-scarring shedding condition

Retatrutide may appeal more to people who have tried single-agonist GLP-1 medications without reaching their desired results, or those looking for a treatment with potentially greater weight loss outcomes

For the best results, this higher dose should always be combined with a balanced diet, controlled portion sizes, and regular physical activity